(February 16, 2021, 2:12 PM EST) -- BROOKLYN, N.Y. — A biotechnology company and certain of its senior executives violated federal securities laws by misrepresenting the impact the novel coronavirus pandemic was having on the company’s submission schedule...
BioTech Company Named In Investor Suit Over COVID-Related Nondisclosures
To view the full article, register now.
Try for FREE for fourteen days
Already a subscriber? Click here to login